Article: Transparent Inc. to Introduce Cell-able, a Unique Human Hepatocyte Array, to U.S. Market at ISSX Meeting.

Novel Culture System Establishes Single Platform to Evaluate Total Liver Function

CHIBA, Japan, Oct. 13 /PRNewswire/ -- Transparent, Inc., a bio-venture business headquartered here, announced today that it will be introducing Cell-able (http://www.cell-able.com/), a human hepatocyte array kit that has the potential to reduce drug development costs and time-to-market for pharmaceutical companies, at its exhibit at the annual meeting of the International Society for the Study of Xenobiotics (http://www.issx.org/ ) in Baltimore, Maryland, October 18-22.

It is estimated that more than ten percent of drug development projects are halted after entering ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!